Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
暂无分享,去创建一个
M. Zucchetti | A. Bardelli | A. D. Dei Tos | A. Pisacane | S. Ferrari | P. Picci | S. Stacchiotti | M. D’Incalci | M. Aglietta | G. Grignani | R. Piana | R. Bertulli | A. Bartolini | E. Palmerini | D. Sangiolo | Giulia Chiabotto | F. Tolomeo | Y. Pignochino | L. Novara | L. D'ambrosio | P. Boccone | E. Marchesi | S. Aliberti | Sara Miano | L. D'Ambrosio | Luca Novara